WHO authorizes Johnson & Johnson’s COVID-19 vaccine
Fox News
The World Health Organization on Friday granted emergency use listing to a single-dose coronavirus vaccine developed by Johnson & Johnson, marking the fourth jab cleared to rollout among developing countries through a global initiative called COVAX.
"We hope that this new vaccine will help to narrow vaccine inequalities and not deepen them," Tedros said. He added that the COVAX facility booked 500 million doses of the single-shot vaccine, and looks forward to receiving the vaccines as soon as possible, potentially by July. The director-general noted the COVAX initiative has delivered about 30 million doses of vaccine across 38 countries.More Related News
Clonazepam, popular anxiety-reducing drug, recalled nationwide for ‘possibly life-threatening’ error
The anxiety-reducing drug, Clonazepam, has been recalled after a potentially "life-threatening" label mix-up, the FDA said in the recall.